• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LRRK2 激酶活性介导果蝇模型中遗传突变与氧化应激之间的毒性相互作用:姜黄素的抑制作用。

LRRK2 kinase activity mediates toxic interactions between genetic mutation and oxidative stress in a Drosophila model: suppression by curcumin.

机构信息

Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi, PR China.

出版信息

Neurobiol Dis. 2012 Sep;47(3):385-92. doi: 10.1016/j.nbd.2012.05.020. Epub 2012 Jun 2.

DOI:10.1016/j.nbd.2012.05.020
PMID:22668778
Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by selective loss of dopaminergic neurons and the presence of Lewy bodies. The pathogenesis of PD is believed to involve both genetic susceptibility and environmental factors. Mutations in Leucine-rich repeat kinase 2 (LRRK2) cause genetic forms of PD, and the LRRK2 locus contributes to sporadic PD. Environmental toxins are believed to act in part by causing oxidative stress. Here we employed cell and Drosophila models to investigate the interaction between LRRK2 genetic mutations and oxidative stress. We found that H(2)O(2) increased LRRK2 kinase activity and enhanced LRRK2 cell toxicity in cultured cells and mouse primary cortical neurons. Furthermore, a sub-toxic dose of H(2)O(2) significantly shortened the survival of LRRK2 transgenic flies and augmented LRRK2-induced locomotor defects and dopamine neuron loss. Treatment with a LRRK2 kinase inhibitor (GW5074) or an anti-oxidant (curcumin) significantly suppressed these PD-like phenotypes in flies. Moreover, curcumin significantly reduced LRRK2 kinase activity and the levels of oxidized proteins, and thus acted as not only an antioxidant but also a LRRK2 kinase inhibitor. These results indicate that LRRK2 genetic alterations can interact with oxidative stress, converging on a pathogenic pathway that may be related to PD. These studies also identified curcumin as a LRRK2 kinase inhibitor that may be a useful candidate for LRRK2-linked PD intervention.

摘要

帕金森病(PD)是一种神经退行性疾病,其特征是多巴胺能神经元选择性丧失和路易体的存在。PD 的发病机制被认为涉及遗传易感性和环境因素。富亮氨酸重复激酶 2(LRRK2)突变导致遗传形式的 PD,LRRK2 基因座与散发性 PD 有关。环境毒素被认为部分通过引起氧化应激而起作用。在这里,我们使用细胞和果蝇模型来研究 LRRK2 基因突变与氧化应激之间的相互作用。我们发现 H₂O₂增加了 LRRK2 激酶活性,并增强了培养细胞和小鼠原代皮质神经元中的 LRRK2 细胞毒性。此外,亚毒性剂量的 H₂O₂显著缩短了 LRRK2 转基因果蝇的寿命,并加剧了 LRRK2 诱导的运动缺陷和多巴胺神经元丢失。用 LRRK2 激酶抑制剂(GW5074)或抗氧化剂(姜黄素)处理可显著抑制果蝇中的这些 PD 样表型。此外,姜黄素显著降低了 LRRK2 激酶活性和氧化蛋白水平,因此不仅是一种抗氧化剂,也是一种 LRRK2 激酶抑制剂。这些结果表明,LRRK2 基因突变可以与氧化应激相互作用,汇聚在一条可能与 PD 相关的致病途径上。这些研究还确定了姜黄素作为 LRRK2 激酶抑制剂,可能是 LRRK2 相关 PD 干预的有用候选药物。

相似文献

1
LRRK2 kinase activity mediates toxic interactions between genetic mutation and oxidative stress in a Drosophila model: suppression by curcumin.LRRK2 激酶活性介导果蝇模型中遗传突变与氧化应激之间的毒性相互作用:姜黄素的抑制作用。
Neurobiol Dis. 2012 Sep;47(3):385-92. doi: 10.1016/j.nbd.2012.05.020. Epub 2012 Jun 2.
2
Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.LRRK2 激酶抑制剂可减轻秀丽隐杆线虫和果蝇帕金森病模型中的神经退行性变和帕金森样表型。
Hum Mol Genet. 2011 Oct 15;20(20):3933-42. doi: 10.1093/hmg/ddr312. Epub 2011 Jul 18.
3
The Drosophila hep pathway mediates Lrrk2-induced neurodegeneration.果蝇hep通路介导Lrrk2诱导的神经退行性变。
Biochem Cell Biol. 2018 Aug;96(4):441-449. doi: 10.1139/bcb-2017-0262. Epub 2017 Dec 21.
4
The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis.酪氨酸羟化酶-多巴胺通路在帕金森病发病机制中的作用。
Cell Mol Life Sci. 2022 Nov 21;79(12):599. doi: 10.1007/s00018-022-04574-x.
5
LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity.LRRK2 通过其激酶活性增强氧化应激诱导的神经毒性。
Exp Cell Res. 2010 Feb 15;316(4):649-56. doi: 10.1016/j.yexcr.2009.09.014. Epub 2009 Sep 19.
6
Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson's disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2).液泡蛋白分选蛋白35(Vps35)可挽救表达富含亮氨酸重复激酶2(LRRK2)帕金森病突变体的果蝇的运动缺陷并延长其寿命。
Mol Neurodegener. 2014 Jun 11;9:23. doi: 10.1186/1750-1326-9-23.
7
Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila.硫醇过氧化物酶可改善果蝇中由LRRK2突变体诱导的线粒体和多巴胺能神经元变性。
Hum Mol Genet. 2014 Jun 15;23(12):3157-65. doi: 10.1093/hmg/ddu026. Epub 2014 Jan 23.
8
Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein.富含亮氨酸重复激酶 2 通过类似动力蛋白的蛋白扰乱线粒体动力学。
J Neurochem. 2012 Aug;122(3):650-8. doi: 10.1111/j.1471-4159.2012.07809.x. Epub 2012 Jun 22.
9
LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis.LRRK2 控制着突触内吞作用中的内收蛋白 A 的磷酸化循环。
Neuron. 2012 Sep 20;75(6):1008-21. doi: 10.1016/j.neuron.2012.08.022.
10
RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.RAB7L1 与 LRRK2 相互作用,改变神经元内蛋白质的分拣,从而影响帕金森病的发病风险。
Neuron. 2013 Feb 6;77(3):425-39. doi: 10.1016/j.neuron.2012.11.033.

引用本文的文献

1
LRRK2-mediated mitochondrial dysfunction in Parkinson's disease.帕金森病中由LRRK2介导的线粒体功能障碍
Biochem J. 2025 May 28;482(11):BCJ20253062. doi: 10.1042/BCJ20253062.
2
LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson's Disease.果蝇模型中的LRRK2:对帕金森病细胞功能障碍和神经炎症的见解
Int J Mol Sci. 2025 Feb 27;26(5):2093. doi: 10.3390/ijms26052093.
3
Neuroprotective Effects of the Nutraceutical Dehydrozingerone and Its C-Symmetric Dimer in a Drosophila Model of Parkinson's Disease.
营养保健品脱氢姜酮及其 C-对称二聚体在帕金森病果蝇模型中的神经保护作用。
Biomolecules. 2024 Feb 24;14(3):273. doi: 10.3390/biom14030273.
4
LRRK2; Communicative Role in the Treatment of Parkinson's Disease and Ulcerative Colitis Overlapping.LRRK2 在治疗帕金森病和溃疡性结肠炎重叠中的交流作用。
CNS Neurol Disord Drug Targets. 2024;23(10):1177-1188. doi: 10.2174/0118715273270874231205050727.
5
Senolytic and senomorphic secondary metabolites as therapeutic agents in models of Parkinson's disease.作为帕金森病模型治疗药物的溶酶体衰老清除剂和衰老形态调节剂次级代谢产物
Front Neurol. 2023 Sep 28;14:1271941. doi: 10.3389/fneur.2023.1271941. eCollection 2023.
6
Rotenone Blocks the Glucocerebrosidase Enzyme and Induces the Accumulation of Lysosomes and Autophagolysosomes Independently of LRRK2 Kinase in HEK-293 Cells.鱼藤酮阻断葡萄糖脑苷脂酶并诱导溶酶体和自噬溶酶体的积累,而不依赖于 HEK-293 细胞中的 LRRK2 激酶。
Int J Mol Sci. 2023 Jun 24;24(13):10589. doi: 10.3390/ijms241310589.
7
The Relationship between Iron and LRRK2 in a 6-OHDA-Induced Parkinson's Disease Model.铁与 LRRK2 在 6-OHDA 诱导的帕金森病模型中的关系。
Int J Mol Sci. 2023 Feb 13;24(4):3709. doi: 10.3390/ijms24043709.
8
Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity.评估当前检测细胞亮氨酸丰富重复激酶 2 (LRRK2)激酶活性的方法。
J Parkinsons Dis. 2022;12(5):1423-1447. doi: 10.3233/JPD-213128.
9
LRRK2 and idiopathic Parkinson's disease.LRRK2 与特发性帕金森病。
Trends Neurosci. 2022 Mar;45(3):224-236. doi: 10.1016/j.tins.2021.12.002. Epub 2022 Jan 4.
10
Curcumin Reduced HO- and G2385R-LRRK2-Induced Neurodegeneration.姜黄素减轻了由HO-和G2385R-LRRK2诱导的神经退行性变。
Front Aging Neurosci. 2021 Oct 15;13:754956. doi: 10.3389/fnagi.2021.754956. eCollection 2021.